HK:1167 Stock Latest News
Company AnnouncementsJacobio Advances KRAS Oncology Pipeline as Glecirasib Gains Traction in China2M ago1167
Company AnnouncementsJacobio Pharmaceuticals Sets Board Meeting to Approve Interim 2026 Results2M ago1167
Company AnnouncementsJacobio Pharmaceuticals Forecasts First Interim Profit on Licensing-Driven Revenue Surge2M ago1167
Company AnnouncementsJacobio Starts Phase IIa Trial of First BET Inhibitor for Rheumatoid Arthritis in China3M ago1167
Company AnnouncementsJacobio Starts Phase Ib/III Trial of Pan-KRAS Inhibitor for KRAS-Mutant Pancreatic Cancer in China3M ago1167
Company AnnouncementsJacobio Pharmaceuticals Launches HK$100 Million Share Buyback Plan4M ago1167Company AnnouncementsJacobio Shareholders Back All Resolutions at 2026 AGM, Renewing Capital Mandates4M ago1167
Company AnnouncementsJacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances5M ago1167
Company AnnouncementsJacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate6M ago1167
Company AnnouncementsJacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug7M ago1167
Company AnnouncementsJacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal7M ago1167
Company AnnouncementsJacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results8M ago1167Company AnnouncementsJacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus9M ago1167
Company AnnouncementsJacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors9M ago1167
- Company AnnouncementsJacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca10M ago1167
Company AnnouncementsJacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline11M ago1167- Company AnnouncementsJacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials11M ago1167
- Company AnnouncementsJacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy11M ago1167
Company AnnouncementsJacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors1y ago1167Company AnnouncementsJacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study1y ago1167
Company AnnouncementsJacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study1y ago1167